Cigna is expanding beyond traditional health insurance into pharmacy services, specialty care, and AI-powered solutions, a strategy that is beginning to deliver results. Its Evernorth health services unit saw adjusted revenues grow 9% year over year to $58.4 billion in the first quarter of 2026. The company is using AI and advanced analytics to streamline prescriptions and identify high-risk patients, while its rebate-free Signature pharmacy model aims to lower out-of-pocket drug costs. Cigna is also reshaping its portfolio with investments in CarepathRx and Shields Health Solutions, and plans to exit the individual exchange business while reviewing strategic alternatives for eviCore. Following a strong first quarter, management raised its 2026 adjusted EPS outlook by 10 cents to at least $30.35 per share.
Cigna CorpCigna raised its 2026 adjusted EPS outlook by 10 cents to at least $30.35 per share after a strong Q1.
CVS Health Corp
British American Tobacco PLC
UnitedHealth Group Incorporated